Using race in clinical research to develop tailored medications. Is the FDA encouraging discrimination or eliminating traditional disparities in health care for African Americans? [electronic resource]
Producer: 20060718Description: 225-41 p. digitalISSN:- 0194-7648
- Black or African American -- genetics
- Clinical Protocols
- Clinical Trials as Topic -- legislation & jurisprudence
- Drug Approval -- legislation & jurisprudence
- Drug Combinations
- Drug Industry -- economics
- Drugs, Investigational
- Heart Failure -- drug therapy
- Humans
- Hydralazine -- therapeutic use
- Isosorbide Dinitrate -- therapeutic use
- Patient Selection
- Pharmacogenetics -- legislation & jurisprudence
- Prejudice
- Socioeconomic Factors
- Supreme Court Decisions
- Treatment Outcome
- United States
- United States Food and Drug Administration
- Vasodilator Agents -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Legal Case
There are no comments on this title.
Log in to your account to post a comment.